Parkinson’s disease: clinical features and diagnosis
Serotonin transporter inhibition attenuates l‐DOPA‐induced dyskinesia without compromising l‐DOPA efficacy in hemi‐parkinsonian rats
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias
Click this link to see recent posters from Bishop Lab!
https://drive.google.com/drive/folders/1OWooWgNDnDwG0WEi0IRUJUJVN1dWSEXn?usp=drive_link
Behavioral Neuroscience Graduate Recruitment Page